ILF3 and hepatocellular carcinoma: Circ-ARL3 sponges miR-1305 and antagonizes the inhibition of miR-1305 on a group of target oncogenes, thereby promoting the progression of HBV+ HCC (90); LncRNA ILF3-AS1 expression is increased in HCC tissues.